MON-461 Drug Repurposing to Explore Novel Treatment for Cushing Disease

Cushing Disease (CD), caused by adrenocorticotropic hormone (ACTH)-secreting pituitary adenomas, leads to excess production of adrenal-derived cortisol. Current medical treatments for CD include adrenal steroidogenesis inhibitors (Ketoconazole, Metyrapone), the somatostatin receptor ligand Pasireoti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Dongyun, Damoisseaux, Robert, Heaney, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550912/
http://dx.doi.org/10.1210/js.2019-MON-461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550912/
http://dx.doi.org/10.1210/js.2019-MON-461

Ejemplares similares